Gahaga Acquired by Hemacell Perfusion

I am sure you all read the news in the FNP Business section today that Gahaga Biosciences (my company) was acquired by Hemacell Perfusion.  Since they were good enough to cover the story, I didn’t want to scoop them.  I just wish they had another picture on file for me.  In that one, I am pretending like I am doing Biodiesel testing.  Funny, but Stem Cells don’t have a Total Acid Number.  Not the viable ones, at least.

I also learned today through a confidential source that Marligen has significantly scaled back operations.  I won’t divulge more than that, but suffice to say that there were a lot of people I had worked with before at Marligen and I am sorry to hear bad news.

And while we’re spreading rumors,  I got a call from a colleague at Lonza-Walkersville who is now looking for work.  I am not sure if this was a wide-spread action or not, but seems like quite a few companies are taking a very close look at their bottom lines.  Except the government, of course.

Has it occurred to anyone how demoralizing it is for the people over at USAMRIID that are “locked out” of their labs during this period of “Inventory Reconciliation”?  A few have confidentially expressed their disgust.  Everyone knows that USAMRIID was like any other Academic institution up until 9/11 and the Anthrax mailing.  Security was lax, but now they expect to be able to recover every single microbe produced there since the 1960’s.  Silly waste of our time and they have hundreds of people sitting around doing nothing until they get the “all clear” from the higher ups.  Talk about a Stimulus Bill.  And I am not talking about Bill Clinton’s nickname….